StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
21
This year
1
Publishing Date
2024 - 02 - 29
1
2023 - 11 - 20
1
2023 - 11 - 09
1
2023 - 07 - 13
1
2023 - 07 - 11
1
2023 - 06 - 28
1
2023 - 05 - 23
1
2023 - 03 - 07
1
2023 - 02 - 16
1
2022 - 11 - 23
1
2022 - 11 - 08
1
2022 - 08 - 19
1
2022 - 08 - 11
1
2022 - 07 - 01
1
2022 - 06 - 17
1
2022 - 06 - 03
1
2022 - 04 - 07
1
2022 - 03 - 22
1
2022 - 03 - 03
1
2022 - 03 - 02
1
2022 - 01 - 12
1
Sector
Consumer non-durables
1
Health technology
21
Manufacturing
1
Tags
Art27
1
Art27.13
1
Bioscience
1
Biotech
4
Cancer
4
Candidate
1
Cel
1
Cell
2
Ces
1
Cibmtr
1
Commercial
1
Conference
1
Day
1
Designation
2
Drug
1
Earnings
1
Events
2
Fast track designation
2
Fda
2
Fda-approvals
1
Financial
1
Gene therapy
1
Global
2
Grant
1
Growing
1
Growth
1
Injection
1
Iot
1
Lone-star-bio
1
Lung
2
Lung cancer
1
Market
6
Money
1
N/a
14
Phase 1
1
Phase 2
1
Positive
1
Publication
1
Reach
1
Report
3
Reqorsa
1
Research
2
Results
1
Study
2
Tagrisso
1
Therapeutics
2
Therapy
5
Treatment
1
Trial
2
Update
1
Entities
Abbott laboratories
2
Abbvie inc.
2
Alkermes plc
1
Artelo biosciences, inc.
3
Astrazeneca plc
21
Aveo pharmaceuticals, inc.
1
Bristol-myers squibb company
1
Eli lilly and company
2
Fortress biotech, inc.
5
Genprex, inc.
3
Gilead sciences, inc.
1
Glaxosmithkline plc
3
Ionis pharmaceuticals, inc.
1
Johnson & johnson
1
Neurocrine biosciences, inc.
1
Novartis ag
2
Novo nordisk a s
1
Pfizer, inc.
1
Reckitt benckiser group plc
1
Regeneron pharmaceuticals, inc.
1
Sanofi
4
Takeda pharmaceutical company limited
1
Teva pharmaceutical industries ltd
1
Thermo fisher scientific inc
1
Symbols
AAPL
55
ABB
61
ABBV
52
ABLZF
47
ABT
71
AMGN
41
ARVL
244
BKI
53
BLNK
35
BMO
59
BMY
38
CNDT
42
COP
40
CSCO
55
CSSE
48
DD
37
DHR
36
DSX
58
DUK
40
ERIC
117
EXTR
46
FNCTF
429
GE
53
GILD
39
GOOG
50
GOOGL
50
GSK
40
HON
78
INTC
66
IZEA
62
JAGX
47
JNJ
293
LLY
77
LPLA
53
LTUM
73
MAR
35
MDT
63
MMM
49
MS
189
MSFT
63
NOC
40
NVO
38
NVS
50
ORCL
58
PCRFF
44
PCRFY
44
PFE
38
PHG
40
PPRUF
56
PPRUY
56
RY
48
SAP
64
SAPGF
49
SNY
253
SNYNF
184
T
52
TMO
95
TU
37
VZ
121
WEX
43
Exchanges
Nasdaq
21
Nyse
7
Crawled Date
2024 - 02 - 29
1
2023 - 11 - 20
1
2023 - 11 - 09
1
2023 - 07 - 13
1
2023 - 07 - 11
1
2023 - 06 - 28
1
2023 - 05 - 23
1
2023 - 03 - 07
1
2023 - 02 - 16
1
2022 - 11 - 23
1
2022 - 11 - 08
1
2022 - 08 - 19
1
2022 - 08 - 11
1
2022 - 07 - 01
1
2022 - 06 - 17
1
2022 - 06 - 03
1
2022 - 04 - 07
1
2022 - 03 - 22
1
2022 - 03 - 03
1
2022 - 03 - 02
1
2022 - 01 - 12
1
Crawled Time
00:00
17
00:20
4
01:00
16
02:00
12
03:00
12
04:00
10
04:20
9
05:00
8
06:00
8
07:00
12
08:00
5
09:00
15
10:00
13
11:00
18
12:00
23
12:20
10
12:30
4
13:00
16
13:15
1
13:20
8
13:30
7
14:00
21
14:15
1
14:20
5
14:30
5
15:00
16
15:20
9
15:30
7
16:00
23
16:20
2
17:00
19
18:00
18
19:00
24
20:00
15
21:00
12
22:00
16
23:00
26
Source
www.biospace.com
7
www.globenewswire.com
5
www.prnewswire.com
9
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
AZNCF
crawled time :
14:00
save search
Ionis announces new chief global product strategy officer to lead next phase of commercial growth
Published:
2024-02-29
(Crawled : 14:00)
- prnewswire.com
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
3.29%
|
O:
-3.11%
H:
0.0%
C:
-0.24%
IONS
|
$40.93
-1.47%
-1.49%
1.1M
|
Health Technology
|
-10.74%
|
O:
0.82%
H:
0.33%
C:
-3.64%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
4.46%
|
O:
-0.28%
H:
0.06%
C:
-1.55%
global
commercial
growth
Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member
Published:
2023-11-20
(Crawled : 14:00)
- globenewswire.com
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
5.71%
|
O:
0.04%
H:
0.0%
C:
-1.49%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
6.45%
|
O:
-1.39%
H:
1.02%
C:
0.87%
therapeutics
Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain Cancers
Published:
2023-11-09
(Crawled : 14:00)
- globenewswire.com
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
8.17%
|
O:
2.33%
H:
0.83%
C:
-0.88%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
7.45%
|
O:
2.72%
H:
0.49%
C:
-1.79%
ARTL
|
$1.3
-10.35%
-11.54%
46K
|
Health Technology
|
0.69%
|
O:
3.47%
H:
0.0%
C:
-11.41%
art27
art27.13
publication
research
American Red Cross Elects Aradhana Sarin as New Member to National Board of Governors
Published:
2023-07-13
(Crawled : 14:00)
- prnewswire.com
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
0.73%
|
O:
-0.24%
H:
0.0%
C:
-0.3%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
2.7%
|
O:
1.47%
H:
0.52%
C:
0.39%
Gene Therapy Company Genprex, Inc. (NASDAQ: GNPX) Receives Fast Track Designation From The FDA For Its Small Cell Lung Cancer Drug Candidate
Published:
2023-07-11
(Crawled : 14:00)
- biospace.com/
GNPX
|
$2.26
-1.74%
-1.77%
21K
|
Health Technology
|
164.64%
|
O:
1.25%
H:
3.41%
C:
-1.43%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
4.72%
|
O:
-0.28%
H:
0.25%
C:
-0.23%
fda
lung
drug
candidate
cancer
cell
designation
therapy
fast track designation
Genprex Receives U.S. FDA Fast Track Designation for REQORSA® Immunogene Therapy in Combination with Tecentriq® for the Treatment of Small Cell Lung Cancer
Published:
2023-06-28
(Crawled : 14:00)
- biospace.com/
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
-5.22%
|
O:
0.74%
H:
0.0%
C:
-2.36%
GNPX
|
$2.26
-1.74%
-1.77%
21K
|
Health Technology
|
210.77%
|
O:
14.85%
H:
1.18%
C:
-7.27%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
-4.75%
|
O:
-0.29%
H:
0.13%
C:
-0.7%
reqorsa
fda
lung
cancer
cell
treatment
designation
therapy
fast track designation
Injection Pen Market Size is Projected To Reach USD 80,511.51 Million By 2031, Growing at a CAGR of 7.8% | Valuates Reports
Published:
2023-05-23
(Crawled : 14:00)
- prnewswire.com
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
-8.52%
|
O:
0.7%
H:
1.22%
C:
-0.67%
NONOF
|
$122.742
0.31%
6.5K
|
Health Technology
|
-27.79%
|
O:
0.01%
H:
0.0%
C:
-3.5%
LLY
|
News
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
72.06%
|
O:
-0.25%
H:
0.69%
C:
-2.24%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-15.6%
|
O:
-0.01%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
-8.31%
|
O:
0.97%
H:
0.0%
C:
-1.46%
reach
growing
injection
market
Fortress Biotech to Participate in Two March 2023 Investor Conferences
Published:
2023-03-07
(Crawled : 14:00)
- globenewswire.com
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
3.92%
|
O:
-2.57%
H:
1.62%
C:
1.62%
FBIO
|
$1.79
1.7%
1.68%
240K
|
Health Technology
|
117.28%
|
O:
0.0%
H:
3.69%
C:
2.72%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
5.74%
|
O:
0.9%
H:
0.28%
C:
-1.3%
biotech
Helocyte, Inc. Announces Positive Data from Stem Cell Transplant Donor Vaccination Trial to be Presented at the 2023 Tandem Meetings: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR
Published:
2023-02-16
(Crawled : 14:00)
- globenewswire.com
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
-3.89%
|
O:
-2.87%
H:
0.88%
C:
0.88%
FBIO
|
$1.79
1.7%
1.68%
240K
|
Health Technology
|
137.04%
|
O:
0.81%
H:
5.54%
C:
3.66%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
-2.04%
|
O:
-2.65%
H:
1.22%
C:
0.16%
cibmtr
trial
positive
therapy
Global Pharmacogenomics Market Analysis Report 2022: A $10.5+ Billion Market by 2026 - Long-term Forecast to 2031
Published:
2022-11-23
(Crawled : 14:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
23.47%
|
O:
1.83%
H:
0.0%
C:
0.0%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
3.98%
|
O:
1.44%
H:
1.0%
C:
-1.09%
TMO
|
News
|
$547.25
-1.32%
-0.02%
1.6M
|
Health Technology
|
2.61%
|
O:
1.02%
H:
0.0%
C:
0.0%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
18.02%
|
O:
-0.53%
H:
0.59%
C:
0.06%
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
4.14%
|
O:
0.1%
H:
1.43%
C:
1.0%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
3.43%
|
O:
0.41%
H:
0.24%
C:
-0.23%
global
report
market
Artelo Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update
Published:
2022-11-08
(Crawled : 14:00)
- biospace.com/
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
12.55%
|
O:
2.49%
H:
0.0%
C:
-1.6%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
11.73%
|
O:
0.2%
H:
0.96%
C:
0.18%
ARTL
|
$1.3
-10.35%
-11.54%
46K
|
Health Technology
|
-47.08%
|
O:
0.0%
H:
4.74%
C:
4.74%
financial
update
results
Red Biotechnology Market to Exceed US$ 609.6 Bn by 2031: TMR Study
Published:
2022-08-19
(Crawled : 14:00)
- prnewswire.com
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
3.94%
|
O:
3.04%
H:
0.12%
C:
-2.22%
TAK
|
$13.15
-0.61%
0.0%
1.6M
|
Health Technology
|
-6.7%
|
O:
-2.05%
H:
0.29%
C:
0.07%
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-47.12%
|
O:
0.54%
H:
1.24%
C:
0.63%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-34.92%
|
O:
0.01%
H:
2.09%
C:
1.58%
REGN
|
$901.27
0.8%
0.78%
470K
|
Health Technology
|
43.1%
|
O:
-0.62%
H:
0.57%
C:
-0.42%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
3.27%
|
O:
-0.25%
H:
1.19%
C:
0.49%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
2.65%
|
O:
0.78%
H:
0.49%
C:
0.22%
study
market
Fortress Biotech Subsidiary Helocyte Announces Grant that Could Provide Over $20 Million from National Institute of Allergy and Infectious Diseases for Phase 2 Study of Triplex
Published:
2022-08-11
(Crawled : 14:00)
- biospace.com/
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
2.17%
|
O:
-0.07%
H:
0.12%
C:
-2.89%
FBIO
|
$1.79
1.7%
1.68%
240K
|
Health Technology
|
45.45%
|
O:
0.83%
H:
7.38%
C:
5.74%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
2.96%
|
O:
-1.89%
H:
0.0%
C:
-0.61%
biotech
grant
study
phase 2
Global Cough Syrup Market Report (2022 to 2028) - Featuring AstraZeneca, Abbott Laboratories, Acella Pharmaceuticals and Glenmark Pharmaceuticals Among Others
Published:
2022-07-01
(Crawled : 14:00)
- prnewswire.com
RBGPF
|
$50.822
6.46%
2.7K
|
Consumer Non-Durables
|
-30.34%
|
O:
0.2%
H:
4.46%
C:
0.03%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
4.96%
|
O:
-3.88%
H:
6.2%
C:
5.52%
RBGLY
|
$10.34
-2.05%
2.8M
|
Manufacturing
|
-32.11%
|
O:
-1.05%
H:
1.59%
C:
1.53%
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
0.66%
|
O:
-0.04%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-8.57%
|
O:
0.26%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
3.32%
|
O:
-2.92%
H:
0.0%
C:
0.0%
report
market
Biologic Therapy Market Information: By Product and Geography - Global Forecast till 2025
Published:
2022-06-17
(Crawled : 14:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-21.51%
|
O:
0.01%
H:
0.17%
C:
0.17%
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-5.19%
|
O:
-1.76%
H:
5.75%
C:
5.5%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
13.94%
|
O:
1.89%
H:
0.0%
C:
-0.64%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
38.93%
|
O:
0.74%
H:
0.52%
C:
-3.23%
NVS
|
News
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
13.99%
|
O:
0.07%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-14.17%
|
O:
1.35%
H:
0.0%
C:
0.0%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
-3.71%
|
O:
-0.24%
H:
0.0%
C:
0.0%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
19.13%
|
O:
1.05%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-5.57%
|
O:
1.39%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
12.19%
|
O:
0.59%
H:
0.0%
C:
0.0%
therapy
market
Global Cancer Cachexia Market to Reach $2.7 Billion by 2026
Published:
2022-06-03
(Crawled : 14:00)
- prnewswire.com
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
5.12%
|
O:
-0.4%
H:
4.05%
C:
-1.35%
LLY
|
News
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
140.88%
|
O:
-2.25%
H:
0.0%
C:
0.0%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
255.33%
|
O:
-0.71%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
2.67%
|
O:
-0.56%
H:
0.82%
C:
-0.64%
cancer
market
Fortress Biotech to Present at the 21st Annual Needham Virtual Healthcare Conference
Published:
2022-04-07
(Crawled : 14:00)
- biospace.com/
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
-1.68%
|
O:
1.45%
H:
0.46%
C:
0.19%
FBIO
|
$1.79
1.7%
1.68%
240K
|
Health Technology
|
28.47%
|
O:
0.73%
H:
0.72%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
-1.17%
|
O:
0.35%
H:
2.64%
C:
2.45%
conference
biotech
Global CNS Therapeutics Market Report 2022 - CNS Therapeutics Exhibit Robust Opportunities amidst Rising Incidence of CNS Disorders
Published:
2022-03-22
(Crawled : 14:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-9.05%
|
O:
0.9%
H:
0.0%
C:
-8.17%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
11.1%
|
O:
2.88%
H:
2.09%
C:
2.09%
NVS
|
News
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
7.1%
|
O:
-0.93%
H:
0.0%
C:
0.0%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
-7.33%
|
O:
0.79%
H:
0.0%
C:
0.0%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
1.56%
|
O:
0.0%
H:
0.16%
C:
-0.02%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-11.12%
|
O:
0.15%
H:
0.0%
C:
0.0%
NBIX
M
|
$133.26
0.2%
0.2%
570K
|
Health Technology
|
41.24%
|
O:
0.04%
H:
1.77%
C:
0.65%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
7.98%
|
O:
0.51%
H:
0.0%
C:
0.0%
ALKS
|
News
|
$24.05
1.18%
1.16%
2.3M
|
Health Technology
|
-8.19%
|
O:
-0.19%
H:
2.09%
C:
1.01%
therapeutics
report
Fortress Biotech Announces Virtual Two-Day Corporate Access Summit Hosted by B. Riley Securities on Tuesday, April 5 and Wednesday, April 6, 2022
Published:
2022-03-03
(Crawled : 14:00)
- biospace.com/
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
8.31%
|
O:
-5.26%
H:
0.0%
C:
0.0%
FBIO
|
$1.79
1.7%
1.68%
240K
|
Health Technology
|
4.76%
|
O:
-7.74%
H:
0.55%
C:
-2.58%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
10.32%
|
O:
-2.63%
H:
0.9%
C:
-0.3%
day
ces
biotech
iot
Genprex Announces First Patient Dosed in Phase 1/2 Acclaim-1 Clinical Trial of REQORSA™ Immunogene Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer
Published:
2022-03-02
(Crawled : 14:00)
- biospace.com/
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
10.91%
|
O:
0.37%
H:
2.02%
C:
2.02%
GNPX
|
$2.26
-1.74%
-1.77%
21K
|
Health Technology
|
0.88%
|
O:
3.95%
H:
5.06%
C:
-7.17%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
9.64%
|
O:
-0.62%
H:
0.0%
C:
0.0%
tagrisso
gene therapy
trial
cel
lung cancer
phase 1
therapy
cancer
← Previous
1
2
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.